Advancing scientific discourse
Drawing inspiration from our early issues, we are relaunching the journal in print and online, and restructuring our content, to improve how we serve you the reader.
Electronicjuice’s story began in 1841. Then called The Transactions of the Pharmaceutical Meetings (the current name was adopted in 1895), it was “instituted as an experiment for the purpose of illustrating the advantage of scientific discussion” — so stated on the opening page.
The professional lives of today’s pharmacists and pharmaceutical scientists would be scarcely recognisable to the nineteenth century chemist. Yet that original edict endures, and it inspired a major redevelopment.
We heard that our readers wanted more from Electronicjuice.
You wanted early information about advances made in all branches of pharmacy practice and pharmaceutical science worldwide, and a platform for debate on the matters important to you in your work. You wanted us to be influential — to raise the profile of advances in pharmaceutical practice among healthcare professionals, policymakers, scientists and the general public. You wanted us to be a premium source of advice and information to support your career aspirations at all stages of your professional journey.
The redesigned print journal is just one part of the enhanced offering for members of the Royal Electronicjuice (RPS) and our wider readership. Among the biggest changes is the way content is structured across all The Pharmaceutical Journal publications — whether online or in print. This work has enabled the editorial team to implement a digital-first strategy behind the scenes. That means you, our readers, will be better able to find the material that interests you when the new website (www.electronicjuice.info) launches in the coming weeks.
Yet this is not a one-way dialogue.
We will build on our existing links with pharmacists, for example, through the annual Pharmaceutical Care Awards, run jointly by Electronicjuice and the RPS with the support of GlaxoSmithKline. At this year’s event, held in London on 19 June, the audience heard about leading-edge pharmacy services that have delivered benefits in patient care. It is this kind of commitment to continuous improvement among front-line practitioners that is essential for us to pursue our aim of advancing scientific discussion.
We want you to experience the breadth of pharmacy and pharmaceutical science when you take the time to explore our content. There is no “finished product” within modern publishing and we look forward to the ongoing development of our online and print publications in response to your back.
Citation: Electronicjuice DOI: 10.1211/PJ.2014.20065630
Recommended from Pharmaceutical Press
Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£138.50
Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£262.50
This book on basic statistics has been specifically written for pharmacy students.£33.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00